Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition.
about
Mirk kinase inhibition targets ovarian cancer ascites.Mirk/dyrk1B kinase is upregulated following inhibition of mTOR.The DREAM complex: master coordinator of cell cycle-dependent gene expression.Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells.The Tumor Suppressor NKX3.1 Is Targeted for Degradation by DYRK1B KinaseMirk/dyrk1B Kinase in Ovarian Cancer.A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr(286), not Thr(288).Targeting DYRK1B suppresses the proliferation and migration of liposarcoma cells.MuvB: A Key to Cell Cycle Control in Ovarian Cancer.
P2860
Q33925352-3BA83718-C00C-4D94-89B0-F996EAE5A38BQ34096774-8596F20B-6F04-419A-AC84-108EE144B7B1Q34356659-97F153E5-10B1-4F20-9693-3A5B68AAB5F6Q34405468-EEF6ED95-2E65-4561-9F2C-F799BD13FF66Q35578920-95658BD3-8A1B-4ACD-94EC-538492FABB3BQ40044634-AAD8394F-C1A4-4DB6-A1D0-1B4C5F6A2DEEQ42708880-B84CD0A2-0CB9-479D-9D58-253D69059CBFQ52641599-2FBED1E9-F3AD-4163-B57D-F301E7D601E1Q55286778-A92B00A9-F975-4934-9366-E9B9BAB21C18
P2860
Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition.
@ast
Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition.
@en
type
label
Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition.
@ast
Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition.
@en
prefLabel
Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition.
@ast
Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition.
@en
P2093
P2860
P356
P1476
Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition.
@en
P2093
Eileen A Friedman
Holly Deng
P2860
P304
P356
10.1002/IJC.27917
P577
2012-11-21T00:00:00Z